Evaluation of the company price cannot be placed u

Evaluation of the company price cannot be placed upon the market or share price at this point. It’s obvious that retail investors are not parting with their shares and Aspire doesn’t hold enough for a large Pharma to gain any sort of control; and if they purchase on the open market it would send this thing sky rocketing anyway. Large Pharma is not depressing the price, as some say, so this can go BK; they would be bidding against any and all participants looking for the assets as a foreclosed home hits the county steps. It’s not Big Pharma’s game and it’s not what’s happening here. They will pay for what the assets are worth and they have people whom have spent their whole lives and education to make that determination, not IHub posters.

MMs are manipulating bid and ask as they see volume come in or leave. The natural cycle of this stock will not allow this to occur much longer...

If you have money that you can “play” with, then my opinion is to gobble up as much as possible as close to $.40 as you can but don’t let the MM’s walk this up on you. Buy wisely and let them sweat till news. It is coming...


Misrepresentations and revilement have completely taken over this board but one must assume this is what will occur when silence is the only voice to consider.